Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1975 Dec;56(6):1663–1672. doi: 10.1172/JCI108248

Flaujeac trait. Deficiency of human plasma kininogen.

K D Wuepper, D R Miller, M J Lacombe
PMCID: PMC333145  PMID: 127805

Abstract

Flaujeac trait plasma resembled Hageman trait or Fletcher trait, in that the intrinsic coagulation pathway, plasma fibinolytic pathway, kinin-forming system, permeability factor of dilution (PF/dil) phenomenon were abnormal. The defect in each assay was reconstituted by afactor separable from Hageman factor or Fletcher factor. This substance was an alpha-globulin with an approximate mol wt of 170,000. Flaujeac plasma did not release a kinin upon incubation with kallikrein and was deficient in total kininogen antigen. Antiserum to kininogen inhibited the activity of the factor in solution. Flaufeac factor was identified as a kininogen of high molecular weight (HMW-kininogen). The mean total kininogen antigen in four children of the proposita was 51% (range 34-62%) of normal. A functional coagulation assay of HMW-kininogen in the children was 34% (range 23-55%). The results were consistent with autosomal recessive inheritance. The plasma pathways of intrinsic coagulation, fibrinolysis, kinin formation, and PF/dil generation are dependent upon HMW-kininogen. We believe this is the first demonstration of biological function for a kininogen apart from its role as a substrate for kallikreins.

Full text

PDF
1663

Images in this article

1668Image
on p.1668

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hathaway W. E., Alsever J. The relation of 'Fletcher Factor' to factors XI and XII. Br J Haematol. 1970 Feb;18(2):161–169. doi: 10.1111/j.1365-2141.1970.tb01431.x. [DOI] [PubMed] [Google Scholar]
  2. Hathaway W. E., Belhasen L. P., Hathaway H. S. Evidence for a new plasma thromboplastin factor. I. Case report, coagulation studies and physicochemical properties. Blood. 1965 Nov;26(5):521–532. [PubMed] [Google Scholar]
  3. IATRIDIS S. G., FERGUSON J. H. Effect of surface and Hageman factor on the endogenous or spontaneous activation of the fibrinolytic system. Thromb Diath Haemorrh. 1961 Dec 15;6:411–423. [PubMed] [Google Scholar]
  4. Jacobsen S. Separation of 2 different substrates for plasma kinin-forming enzymes. Nature. 1966 Apr 2;210(5031):98–99. doi: 10.1038/210098a0. [DOI] [PubMed] [Google Scholar]
  5. Komiya M., Kato H., Suzuki T. Bovine plasma kininogens. I. Further purification of high molecular weight kininogen and its physicochemical properties. J Biochem. 1974 Oct;76(4):811–822. [PubMed] [Google Scholar]
  6. Komiya M., Kato H., Suzuki T. Bovine plasma kininogens. II. Microheterogeneities of high molecular weight kininogens and their structural relationships. J Biochem. 1974 Oct;76(4):823–832. [PubMed] [Google Scholar]
  7. Lacombe M. J. Déficit constitutionnel en un nouveau facteur de la coagulation intervenant au niveau de contact: le facteur "Flaujeac". C R Acad Sci Hebd Seances Acad Sci D. 1975 Feb 24;280(8):1039–1041. [PubMed] [Google Scholar]
  8. Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966 Apr;15(1):45–52. doi: 10.1016/0003-2697(66)90246-6. [DOI] [PubMed] [Google Scholar]
  9. MACKAY M. E., MILES A. A., SCHACHTER M., WILHELM D. L. Susceptibility of the guinea pig to pharmacological factors from its own serum. Nature. 1953 Oct 17;172(4381):714–716. doi: 10.1038/172714b0. [DOI] [PubMed] [Google Scholar]
  10. MARGOLIS J. Activation of plasma by contact with glass: evidence for a common reaction which releases plasma kinin and initiates coagulation. J Physiol. 1958 Nov 10;144(1):1–22. doi: 10.1113/jphysiol.1958.sp006082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. MILES A. A. LARGE MOLECULAR SUBSTANCES AS MEDIATORS OF THE INFLAMMATORY REACTION. Ann N Y Acad Sci. 1964 Aug 27;116:855–865. doi: 10.1111/j.1749-6632.1964.tb52551.x. [DOI] [PubMed] [Google Scholar]
  12. NIEWIAROWSKI S., PROU-WARTELLE O. [Role of the contact factor (Hageman factor) in fibrinolysis]. Thromb Diath Haemorrh. 1959 Sep 1;3:593–603. [PubMed] [Google Scholar]
  13. RATNOFF O. D., COLOPY J. E. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest. 1955 Apr;34(4):602–613. doi: 10.1172/JCI103109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Schiffman S., Lee P. Preparation, characterization, and activation of a highly purified factor XI: evidence that a hitherto unrecognized plasma activity participates in the interaction of factors XI and XII. Br J Haematol. 1974 May;27(1):101–114. doi: 10.1111/j.1365-2141.1974.tb06778.x. [DOI] [PubMed] [Google Scholar]
  15. Wuepper K. D. Prekallikrein deficiency in man. J Exp Med. 1973 Dec 1;138(6):1345–1355. doi: 10.1084/jem.138.6.1345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Yano M., Nagasawa S., Horiuchi K., Suzuki T. Separation of a new substrate, kininogen-I, for plasma kallikrein in bovine plasma. J Biochem. 1967 Oct;62(4):504–506. doi: 10.1093/oxfordjournals.jbchem.a128698. [DOI] [PubMed] [Google Scholar]
  17. Yano M., Nagasawa S., Suzuki T. Partial purification and some properties of high molecular weight kininogen, bovine kininogen-I. J Biochem. 1971 Mar;69(3):471–481. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES